Best insulin company in Bangladesh

Searching the Web

best insulin manufacturer company Bangladesh 2025

Here is a clear picture of the insulin landscape in Bangladesh as of 2026:

Best Insulin Companies in Bangladesh

1. Eskayef Pharmaceuticals Ltd. (SK+F) - Top Local Producer

The most significant development in Bangladesh's insulin sector is the Eskayef-Novo Nordisk technology transfer partnership, announced recently. This makes Eskayef the first and only local manufacturer of modern insulin in Bangladesh. Under the deal:
  • Premix and rapid-acting insulin cartridges are now produced domestically for the first time
  • Every batch is verified in Denmark to meet global standards
  • Novo Nordisk cut prices by 18% on key products like NovoMix® and NovoRapid® as a result
  • This is a major leap from generic drugs into high-value biologics
Eskayef is ranked 6th overall in Bangladesh's pharma market (IQVIA 2025) but is now the leading name specifically in insulin manufacturing.

2. Novo Nordisk (Global Brand, Distributed in Bangladesh)

The Danish giant is the world's largest insulin producer and has deep presence in Bangladesh through its local unit. Its products (NovoRapid®, NovoMix®, Tresiba®, etc.) are widely prescribed. The partnership with Eskayef extends their reach further.

3. Incepta Pharmaceuticals Ltd.

Ranked 2nd overall in Bangladesh's pharma market, Incepta has a strong biotech division and produces insulin locally. It is known for affordable pricing and wide distribution across the country. Many Bangladeshi doctors rely on Incepta's insulin products for price-sensitive patients.

4. Square Pharmaceuticals PLC

Bangladesh's #1 pharma company with ~17-18% market share overall (IQVIA 2025). Square has a broad portfolio that includes insulin products, backed by the country's most extensive distribution network.

5. Opsonin Pharma Ltd.

A well-established generics manufacturer that also produces insulin formulations. Known for affordability and wide reach in rural areas.

Summary Table

CompanyRoleStrength
Eskayef (SK+F)Local manufacturer (Novo Nordisk partnership)Only domestic modern insulin producer
Novo NordiskGlobal brand, distributed locallyGold standard quality, widest product range
InceptaLocal manufacturer + biotechAffordable, strong biotech pipeline
SquareLocal manufacturerLargest distribution network
OpsoninGenericsAffordable, rural reach

Bottom line: For quality and innovation, the Eskayef-Novo Nordisk partnership is the most significant development right now. For overall availability and trust, Novo Nordisk branded products remain the market leader, while Incepta is the strongest purely local insulin producer. Bangladesh currently has ~13 million diabetics, projected to reach 22 million by 2045, making this a rapidly growing sector.

If i want to buy from one of them, which 2 should i choose?

Asking for Preferences
Since you're buying for a family member and quality is the top priority, the choice is clear:

Your Top 2 Picks: Quality First

🥇 1. Novo Nordisk

The global gold standard for insulin - no other brand comes close for quality.
  • Products to look for: NovoRapid® (fast-acting), NovoMix® 30 (premix), Tresiba® (long-acting)
  • Every batch is manufactured and verified to Danish/EU pharmaceutical standards
  • Used by endocrinologists worldwide as the reference insulin
  • Now partially produced in Bangladesh via the Eskayef partnership, but still verified in Denmark - so quality is unchanged
  • Widely available at all major pharmacies in Dhaka and divisional cities
Best for: reliable blood sugar control, consistent potency, internationally validated safety profile.

🥈 2. Incepta Pharmaceuticals

The best purely local option - strong biotech division and trusted by Bangladeshi doctors.
  • Incepta has invested heavily in its biotech manufacturing, with quality controls significantly above average for local producers
  • Their insulin line is widely trusted by physicians across Bangladesh
  • A good backup or alternative when Novo Nordisk products are temporarily out of stock
  • More affordable than Novo Nordisk, without a major drop in quality
Best for: a reliable local alternative with good doctor confidence and easier pricing.

Why NOT the others?

  • Square - great overall pharma company, but insulin is not their specialty focus
  • Eskayef - promising future, but their local insulin manufacturing is very new (just launched); Novo Nordisk is still the safer bet right now
  • Opsonin - solid for generics but not the top pick when quality is your priority

Final recommendation: Buy Novo Nordisk as the primary insulin for your family member, and keep Incepta as your trusted backup. Always confirm the specific type of insulin (rapid, long-acting, or premix) with the prescribing doctor before purchasing.

Mixtard 50 is not available readily

Searching the Web

Mixtard 50 alternative insulin Bangladesh available pharmacy 2025

This is a very common problem in Bangladesh - Mixtard 50 is much rarer than Mixtard 30. Here's what you can do:

Mixtard 50 is Scarce - Your Best Alternatives in Bangladesh

Mixtard 50 = 50% regular (short-acting) + 50% NPH (intermediate-acting) insulin. The key is finding a local equivalent with the same 50/50 ratio.

Direct 50/50 Substitutes Available in Bangladesh

BrandCompanyType
Ansulin 50/50Square PharmaceuticalsBiphasic human insulin 50/50
Mysulin M 50/50Drug InternationalBiphasic human insulin 50/50
Maxsulin M 50/50Incepta PharmaceuticalsBiphasic human insulin 50/50
Insul M 50/50Popular PharmaceuticalsBiphasic human insulin 50/50
Diasulin 50/50ACIBiphasic human insulin 50/50
These are chemically equivalent to Mixtard 50 - same 50% regular + 50% NPH human insulin.

Top 2 Recommendations (Your Quality Priority)

1. Incepta - Maxsulin M 50/50 Incepta's biotech division has the strongest quality controls among local producers. Maxsulin is their well-established insulin line and widely trusted by endocrinologists.
2. Square - Ansulin 50/50 Square has the largest distribution network in Bangladesh, so it's the easiest to find at pharmacies nationwide. Quality is reliable and consistent.

Important Notes

  • Do not switch to Mixtard 30 (30/70) as a substitute without doctor approval - the ratio difference can significantly affect blood sugar control
  • NovoMix 50 (by Novo Nordisk) is the modern analog equivalent (faster-acting), but requires a doctor's guidance to adjust dosing if switching
  • Always inform your family member's doctor before switching brands, even if the ratio is identical - the doctor may want to monitor during the transition
This is a shared conversation. Sign in to Orris to start your own chat.